Ascension Asset Management’s Pfizer PFE Stock Holding History

Ascension Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$234K	Buy	+6,393	New	+$249K	0.14%	87
2022 Q4	$328K	Buy	6,393 +200	+3%	+$9.59K	0.24%	77
2022 Q3	$280K	Hold	6,193	–	–	0.22%	81
2022 Q2	$325K	Buy	+6,193	New	+$316K	0.24%	79
2021 Q4	$366K	Hold	6,193	–	–	0.22%	74
2021 Q3	$266K	Hold	6,193	–	–	0.17%	78
2021 Q2	$243K	Sell	6,193 -300	-5%	-$11.7K	0.16%	77
2021 Q1	$235K	Buy	+6,493	New	+$231K	0.16%	77
2020 Q4	–	Sell	-7,535	Closed	-$262K	–	82
2020 Q3	$262K	Buy	+7,535	New	+$264K	0.21%	76
2020 Q1	$225K	Hold	7,266	–	–	0.23%	72
2019 Q4	$270K	Hold	7,266	–	–	0.23%	69
2019 Q3	$248K	Hold	7,266	–	–	0.23%	70
2019 Q2	$299K	Sell	7,266 -1,054	-13%	-$41.9K	0.26%	67
2019 Q1	$335K	Hold	8,320	–	–	0.3%	68
2018 Q4	$345K	Hold	8,320	–	–	0.35%	66
2018 Q3	$348K	Sell	8,320 -1,834	-18%	-$70.6K	0.31%	68
2018 Q2	$350K	Sell	10,154 -2,108	-17%	-$72K	0.32%	69
2018 Q1	$413K	Sell	12,262 -1,054	-8%	-$36.2K	0.38%	69
2017 Q4	$458K	Buy	+13,316	New	+$454K	0.42%	67

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ascension Asset Management's PFE Position: Q2 2023 in Review

Ascension Asset Management opened a new position in Pfizer (PFE) in Q2 2023: 6,393 shares worth $234K. The stake represents 0.14% of the portfolio and ranks #87 among its holdings. This is a return to the name: Ascension Asset Management previously reported a position in PFE as recently as Q4 2022.

Ascension Asset Management first reported a position in PFE in Q4 2017 and has held it in 19 quarters since. The position peaked at $458K in Q4 2017. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Ascension Asset Management held 6,393 shares of Pfizer worth $234K as of Q2 2023.
Pfizer was a new Ascension Asset Management position in Q2 2023.
Pfizer made up 0.14% of Ascension Asset Management's portfolio in Q2 2023, its #87 holding.
Ascension Asset Management first reported a position in Pfizer in Q4 2017 and has held it in 19 quarters since.
Ascension Asset Management's Pfizer position peaked at $458K in Q4 2017.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Ascension Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.